ImmunityBio, Inc. today announced positive results in its fully-enrolled metastatic pancreatic cancer study in third-line or greater subjects ( QUILT 88 ), showing that the overall survival (OS) rate for patients continues to be double compared...
Vax Before Cancer
/ January 29th, 2023Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.